IGHE and neoplasm: However, IgE has been developed as an immunotherpeautic agent for cancer, and IgA-based therapeutics have been proposed for treatment of bacterial and viral infections, and as anti-inflammatory and anti-tumor agents (10, 11, 150, 157).